4
Changes in Ownership
NOVAVAX INC Filed Acc 0001209191-21-047809
President, R&D sold 2,409 shares at an average $215.43 ($518,982)
From the SEC's structured data for this filing
Trades in this filing
Glenn Gregory M · President, R&D
Table I: Non-derivative
18 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2021-07-20 | Sale : show line 1 in the form | −119 | $200.61 | $23,872 | 5,101 | D |
| 2021-07-20 | Sale : show line 2 in the form | −199 | $202.76 | $40,348 | 4,902 | D |
| 2021-07-20 | Sale : show line 3 in the form | −61 | $203.39 | $12,407 | 4,841 | D |
| 2021-07-20 | Sale : show line 4 in the form | −119 | $204.71 | $24,360 | 4,722 | D |
| 2021-07-20 | Sale : show line 5 in the form | −181 | $205.66 | $37,225 | 4,541 | D |
| 2021-07-20 | Sale : show line 6 in the form | −135 | $206.82 | $27,920 | 4,406 | D |
| 2021-07-20 | Sale : show line 7 in the form | −126 | $207.63 | $26,161 | 4,280 | D |
| 2021-07-20 | Sale : show line 8 in the form | −63 | $211.93 | $13,352 | 4,217 | D |
| Open-market sales · 2,409 sh · avg $215.43 · $518,982 | ||||||
Loading xslF345X03/doc4.xml…